| Apex Community Health Center Inc | |
|
18040 Sherman Way Ste 204 Reseda CA 91335-4656 | |
| (818) 618-7737 | |
| (747) 267-7878 |
| Full Name | Apex Community Health Center Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 18040 Sherman Way Ste 204, Reseda, California |
| Authorized Official Name and Position | Armine Harutyunyan (CEO) |
| Authorized Official Contact | 8186187737 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Apex Community Health Center Inc 18040 Sherman Way Ste 204 Reseda CA 91335-4656 Ph: (818) 618-7737 | Apex Community Health Center Inc 18040 Sherman Way Ste 204 Reseda CA 91335-4656 Ph: (818) 618-7737 |
| NPI Number | 1639815186 |
|---|---|
| Provider Enumeration Date | 05/09/2022 |
| Last Update Date | 05/09/2022 |
| Medicare PECOS PAC ID | 1557740651 |
|---|---|
| Medicare Enrollment ID | O20221214001845 |
News Archive
A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.
Stroke is the second main cause of death globally, and a major cause of disability. Around 15 million people worldwide suffer a stroke each year, and rates are climbing, with the number of strokes in Europe set to increase by 1.5 million per year by 2025 – due in large part to the aging population.
Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Researchers have shown how ultrasound energy can briefly "open a door" in the protective outer membranes of living cells to allow entry of drugs and other therapeutic molecules – and how the cells themselves can then quickly close the door.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the US market release of the Selectra left ventricular lead delivery system.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639815186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Armine Harutyunyan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598155301 PECOS PAC ID: 2466589312 Enrollment ID: I20150901002986 |
News Archive
A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.
Stroke is the second main cause of death globally, and a major cause of disability. Around 15 million people worldwide suffer a stroke each year, and rates are climbing, with the number of strokes in Europe set to increase by 1.5 million per year by 2025 – due in large part to the aging population.
Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Researchers have shown how ultrasound energy can briefly "open a door" in the protective outer membranes of living cells to allow entry of drugs and other therapeutic molecules – and how the cells themselves can then quickly close the door.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the US market release of the Selectra left ventricular lead delivery system.
› Verified 5 days ago
News Archive
A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.
Stroke is the second main cause of death globally, and a major cause of disability. Around 15 million people worldwide suffer a stroke each year, and rates are climbing, with the number of strokes in Europe set to increase by 1.5 million per year by 2025 – due in large part to the aging population.
Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Researchers have shown how ultrasound energy can briefly "open a door" in the protective outer membranes of living cells to allow entry of drugs and other therapeutic molecules – and how the cells themselves can then quickly close the door.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the US market release of the Selectra left ventricular lead delivery system.
› Verified 5 days ago
Bfm Visits Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18305 Sherman Way Ste 3, Reseda, CA 91335 Phone: 818-477-0798 | |
Cisco Medical Group - Reseda Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 18518 Sherman Way, Reseda, CA 91335 Phone: 818-757-0954 Fax: 818-757-0963 | |
Higher Doctor's Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19231 Sherman Way Unit 23, Reseda, CA 91335 Phone: 818-220-4898 | |
Rst Medical Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18040 Sherman Way Ste 210, Reseda, CA 91335 Phone: 818-796-2920 | |
Med Nation, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7012 Reseda Blvd., Suite A, Reseda, CA 91335 Phone: 818-776-1171 Fax: 818-776-1191 | |
Medical Resource Center Of Tarzana, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18445 Vanowen St, Reseda, CA 91335 Phone: 818-708-8484 Fax: 818-881-7451 | |
Avicenna Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 18445 Vanowen St, Reseda, CA 91335 Phone: 818-708-8484 |